Lisa Schlager[email protected]GuidelineIs the new Medicare NGS payment policy really a win for patients?The implications of the new policy, however, are less positive than what appears at the surface. Patients seeking germline testing are only slightly better off now than they were two years ago, before the NCD was initiated.February 4, 2020Page 1 of 1Top StoriesArtificial IntelligenceAI model could prevent unnecessary treatment for breast cancer patients, says studyBreast cancer patients could be spared unnecessary chemotherapy with the use of a new artificial intelligence (AI) tool that helps predict survival risk, say researchers.FDA ClearanceKSQ Therapeutics receives FDA clearance for trial of CRISPR-Cas9 engineered tumor therapyVascular DiseasePotential drug target to prevent small vessel disease identified in studyTrends and FinanceCandel Therapeutics to lay off 50% of workforce, refocus on advanced oncology immunotherapiesRheumatoid ArthritisScipher Medicine, Quest Diagnostics collaborate on RA diagnostics
